Real-time enrollment status for this moderate-to-severe chronic plaque psoriasis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:07 PM UTC
| NCT Number | NCT07362017 |
| Recruiting Status | Recruiting |
| Condition | Moderate-to-severe Chronic Plaque Psoriasis |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 13, 2026: Clinical trial NCT07362017 is currently recruiting participants. This clinical trial study for moderate-to-severe chronic plaque psoriasis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07362017 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07362017 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.